USNA
USANA Health Sciences Inc
NYSE: USNA · CONSUMER DEFENSIVE · PACKAGED FOODS
$17.99
-3.27% today
Updated 2026-06-03
Market cap
$366.86M
P/E ratio
39.74
P/S ratio
0.40x
EPS (TTM)
$0.50
Dividend yield
—
52W range
$17 – $38
Volume
0.1M
WallStSmart proprietary scores
52
out of 100
Grade: C
Hold
Investment rating
2.7
Growth
F8.5
Quality
A5.0
Profitability
C+5.7
Valuation
C+4/9
Piotroski F-Score
Moderate
4.8
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$39.00
+116.85%
12-Month target
$17.01
-5.42%
Intrinsic (DCF)
—
Margin of safety
—
Price chart
Stock snapshot
Strengths
+ Altman Z 4.82 — safe zone
+ Free cash flow $7.11M — positive
+ Debt/equity 0.03x — low leverage
Risks
- Thin margins at 0.96%
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $998.60M | $921.01M | $854.50M | $925.26M | $925.94M |
| Net income | $69.35M | $63.79M | $42.03M | $10.76M | $7.51M |
| EPS | — | — | — | — | $0.50 |
| Free cash flow | $93.50M | $56.15M | $50.92M | $8.53M | $7.11M |
| Profit margin | 6.94% | 6.93% | 4.92% | 1.16% | 0.96% |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-06-08 | JONES, PAUL A. | Sale | 5,561 | $18.50 |
| 2026-06-01 | FLEMING, JOHN TURMAN | Sale | 2,450 | $17.93 |
| 2026-05-28 | JONES, PAUL A. | Sale | 6,813 | $18.95 |
Peer comparison
Smart narrative
USANA Health Sciences Inc trades at $17.99. representing a P/E of 39.74x trailing earnings. Our Smart Value Score of 52/100 indicates the stock is fair. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 4.82, it sits in the safe zone. TTM revenue stands at $925.94M. with profit margins at 0.96%.
Frequently asked questions
What is USANA Health Sciences Inc's stock price?
USANA Health Sciences Inc (USNA) trades at $17.99, on a P/E of 39.7x and a P/S of 0.4x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is USANA Health Sciences Inc overvalued?
USANA Health Sciences Inc carries a Smart Value Score of 52/100 (Grade C), which we rate Hold. That score blends growth, quality, and valuation into one read.
What is the price target of USANA Health Sciences Inc (USNA)?
The 12-month analyst consensus target is $39.00, about 116.8% above the current $17.99. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is USANA Health Sciences Inc's revenue?
USANA Health Sciences Inc's trailing twelve-month revenue is $925.94M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
USANA Health Sciences Inc's Altman Z-Score is 4.82, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorCONSUMER DEFENSIVE
IndustryPACKAGED FOODS
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio0.40x
ROE1.55%
Beta0.77
50D MA$18.58
200D MA$21.13
Shares out0.02B
Float0.01B
Short ratio—
Avg volume0.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—